Zim Laboratories

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE518E01015
NSEID: ZIMLAB
BSEID: 541400

INR

87.89

1.24 (1.43%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 33.42 k

Click here to access the older version

Company CV

About Zim Laboratories Ltd

Zim Laboratories Ltd

Micro Cap

Pharmaceuticals & Drugs

Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.

Company Coordinates

Company Details

Sadoday Gyan (Gr Floor), Opp NADT Nelson Square Nagpur Maharashtra : 440013

Tel: 91-712-2588070

http://www.zimlab.in

md@zimlab.in

Registrar Details

Capital Structure

Present Equity Capital

INR 48.73 Cr

Number of Shares

4.87 Cr

Face Value

INR 10.0

Date

Number
of Shares(Cr)

Equity
Capital (Rs Cr)

Shares Added

Face Value (Rs)

Reason

22-Dec-2022

4.87

48.73

32483876

Bonus Issue

11-Jul-2020

1.62

16.24

61216

Issued under ESOP Scheme

22-May-2019

1.62

16.18

61216

ESOP

22-May-2019

1.62

16.18

61216

Issued under ESOP Scheme

04-Oct-2018

1.61

16.12

8059753

Bonus

04-Oct-2018

1.61

16.12

8059753

Bonus Issue

07-Jun-2018

80.6

8.06

2059753

Allotment of Equity To Others

11-May-2018

80.6

8.06

As per BSE Notice

31-Mar-2009

6.00

6000000

As per Annual Report

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (0.21%)

Promoter with highest holding

Anwar Daud (27.37%)

Highest Public shareholder

Zakir S Vali (10.36%)

Individual Investors Holdings

44.39%

Board of Directors

Period

Management

Designation

Remuneration

Anwar S Daud

Chairman & Managing Director

1.51 cr

Zulfiquar M Kamal

Director (Finance)

1.06 cr

Prakash Sapkal

Director (Operation)

87.5 lacs

Niraj Dhadiwal

Director (Business Developmnt)

87.5 lacs

Kavita Loya

Non-Exec. & Independent Dir.

9.0 lacs

Padmakar Joshi

Non-Exec. & Independent Dir.

7.0 lacs

Piyush Nikhadi

Company Sec. & Compli. Officer

Kamlesh Shende

Independent Director

7.0 lacs

Kakasaheb Mahadik

Independent Director

7.0 lacs

Raw Materials

Raw Materials Dashboard

Raw Materials

Amount(Rs Cr)

% of RM Cost

No Data Available for Raw Material Segmentation

No Data Available

Finished Goods

Finished Goods Dashboard

Finished Goods

Amount(Rs Cr)

% of Sales Turnover

Pre Formulation Ingredients & Others

247.77

90.64%

Traded Goods

18.65

6.82%

Export Incentives

5.85

2.14%

Pre Formulation Ingredients & Others

Traded Goods

Export Incentives

Stock DNA

Revenue and Profits:

Net Sales:

96 Cr

(Quarterly Results - Dec 2024)

Net Profit:

4 Cr

Industry

Pharmaceuticals & Drugs

Market cap

INR 428 Cr (Micro Cap)

P/E

27.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.39

Return on Equity

6.65%

Price to Book

1.74